Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 26,868 | 31,501 | 13,368 | 106,407 | 28,658 |
| Gross Profit | 26,868 | 31,501 | 13,368 | 106,407 | 28,658 |
| Operating Expenses | 125,735 | 120,417 | 126,764 | 87,720 | 66,065 |
| Operating Income | -98,867 | -88,916 | -113,396 | 18,687 | -37,407 |
| Interest Expense | 27,360 | 21,564 | 16,996 | 2,698 | 268 |
| Other Income | 4,535 | 4,191 | 2,602 | 464 | 174 |
| Pre-tax Income | -121,692 | -106,289 | -127,790 | 16,453 | -37,501 |
| Net Income Continuous | -121,692 | -106,289 | -127,790 | 16,453 | -37,501 |
| Net Income | $-121,692 | $-106,289 | $-127,790 | $16,453 | $-37,501 |
| EPS Basic Total Ops | -2.11 | -1.95 | -2.59 | 0.41 | -0.97 |
| EPS Basic Continuous Ops | -2.11 | -1.95 | -2.59 | 0.41 | -0.97 |
| EPS Diluted Total Ops | -2.11 | -1.95 | -2.59 | 0.39 | -0.97 |
| EPS Diluted Continuous Ops | -2.11 | -1.95 | -2.59 | 0.39 | -0.97 |
| EPS Diluted Before Non-Recurring Items | -2.11 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-97,574 | $-87,677 | $-111,476 | $19,428 | $-36,818 |